{ "source": "Nasdaq Nordic Company News", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "status": "retrieved", "company": "Moberg Pharma", "reports": [ { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:41:47Z", "company": "Moberg Pharma AB", "title": "Delårsrapport januari - mars 2026", "category": "Interimsrapport", "date": "2026-05-12", "language": "sv", "report_type": "interim-report", "fiscal_year": 2026, "quarter": "q1", "period": "2026-q1", "report_key": "2026:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=bd8bfd1621c14ce7d37a887abba216820&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2026-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2026-q1\\release.txt", "attachments": [ { "label": "05111212.pdf", "url": "https://attachment.news.eu.nasdaq.com/a33ca736461d70a771af7251d5d201e1f", "final_url": "https://attachment.news.eu.nasdaq.com/a33ca736461d70a771af7251d5d201e1f", "filename": "05111212.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2026-q1\\05111212.pdf", "content_type": "application/pdf", "size": 648027, "sha256": "eec9efb8ab54a89d5132de2b301defe81e5efcbe56128a634b54614089bd85f6", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2026-q1\\05111212.pdf", "filename": "05111212.pdf", "extension": ".pdf", "size": 648027, "sha256": "eec9efb8ab54a89d5132de2b301defe81e5efcbe56128a634b54614089bd85f6", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2026-q1\\extracted\\05111212\\05111212.txt", "text_chars": 40158, "metadata": { "page_count": 19, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2026-q1\\extracted\\05111212\\05111212.extraction.json" } } ], "announcement_id": "1441465", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:41:59Z", "company": "Moberg Pharma AB", "title": "Moberg Pharmas årsredovisning för räkenskapsåret 2025 offentliggjord", "category": "Övrig information som ska lämnas enligt börsens regler", "date": "2026-04-17", "language": "sv", "report_type": "annual-report", "fiscal_year": 2025, "quarter": "annual", "period": "2025-annual", "report_key": "2025:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b46d473bd96ac88a93171ea16ac123e5d&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-annual\\release.txt", "attachments": [ { "label": "04169804.pdf", "url": "https://attachment.news.eu.nasdaq.com/a0917f6991d6c3be300cd92421349d4be", "final_url": "https://attachment.news.eu.nasdaq.com/a0917f6991d6c3be300cd92421349d4be", "filename": "04169804.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-annual\\04169804.pdf", "content_type": "application/pdf", "size": 3791583, "sha256": "40d505db6959517a590cdf9507121369e549bd7c7964ac2a2613ac4f99c0d832", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-annual\\04169804.pdf", "filename": "04169804.pdf", "extension": ".pdf", "size": 3791583, "sha256": "40d505db6959517a590cdf9507121369e549bd7c7964ac2a2613ac4f99c0d832", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-annual\\extracted\\04169804\\04169804.txt", "text_chars": 236130, "metadata": { "page_count": 67, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-annual\\extracted\\04169804\\04169804.extraction.json" } } ], "announcement_id": "1434942", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:42:01Z", "company": "Moberg Pharma AB", "title": "Moberg Pharma bokslutskommuniké 2025", "category": "Bokslutskommuniké", "date": "2026-02-17", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2025, "quarter": "q4", "period": "2025-q4", "report_key": "2025:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=b40c3e0001360ece8761995aaa378e08a&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q4\\release.txt", "attachments": [ { "label": "02161823.pdf", "url": "https://attachment.news.eu.nasdaq.com/acc11051b4d2bceb57dbf5b2a9ba1ff69", "final_url": "https://attachment.news.eu.nasdaq.com/acc11051b4d2bceb57dbf5b2a9ba1ff69", "filename": "02161823.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q4\\02161823.pdf", "content_type": "application/pdf", "size": 779706, "sha256": "5669c83cdc53f4b22974c53dbab55ceb39718ea34c3a741e04baba6cbc97af06", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q4\\02161823.pdf", "filename": "02161823.pdf", "extension": ".pdf", "size": 779706, "sha256": "5669c83cdc53f4b22974c53dbab55ceb39718ea34c3a741e04baba6cbc97af06", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q4\\extracted\\02161823\\02161823.txt", "text_chars": 42700, "metadata": { "page_count": 20, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q4\\extracted\\02161823\\02161823.extraction.json" } } ], "announcement_id": "1420627", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:42:06Z", "company": "Moberg Pharma AB", "title": "Moberg Pharmas delårsrapport januari - september 2025", "category": "Interimsrapport", "date": "2025-11-11", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q3", "period": "2025-q3", "report_key": "2025:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b25c4bde78c49d222f408727bfd59e045&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q3\\release.txt", "attachments": [ { "label": "11107927.pdf", "url": "https://attachment.news.eu.nasdaq.com/a178f416752247c2e0c187254b6798490", "final_url": "https://attachment.news.eu.nasdaq.com/a178f416752247c2e0c187254b6798490", "filename": "11107927.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q3\\11107927.pdf", "content_type": "application/pdf", "size": 801999, "sha256": "7e4e9819200e47890c19f17e84f6d0d6b47e7a5f6eccada7010068b139befc67", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q3\\11107927.pdf", "filename": "11107927.pdf", "extension": ".pdf", "size": 801999, "sha256": "7e4e9819200e47890c19f17e84f6d0d6b47e7a5f6eccada7010068b139befc67", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q3\\extracted\\11107927\\11107927.txt", "text_chars": 46645, "metadata": { "page_count": 21, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q3\\extracted\\11107927\\11107927.extraction.json" } } ], "announcement_id": "1399883", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:42:10Z", "company": "Moberg Pharma AB", "title": "Delårsrapport januari - juni 2025", "category": "Halvårsrapport", "date": "2025-08-12", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q2", "period": "2025-q2", "report_key": "2025:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b80d2e318ec7fd7fed0b95625c47856fa&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q2\\release.txt", "attachments": [ { "label": "08119244.pdf", "url": "https://attachment.news.eu.nasdaq.com/ac241e37e905facaca03e613f2fe29308", "final_url": "https://attachment.news.eu.nasdaq.com/ac241e37e905facaca03e613f2fe29308", "filename": "08119244.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q2\\08119244.pdf", "content_type": "application/pdf", "size": 661134, "sha256": "73b37b43414bf55370ccc87264a3b665f50ee25abe61b05a9700794d7fffcce8", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q2\\08119244.pdf", "filename": "08119244.pdf", "extension": ".pdf", "size": 661134, "sha256": "73b37b43414bf55370ccc87264a3b665f50ee25abe61b05a9700794d7fffcce8", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q2\\extracted\\08119244\\08119244.txt", "text_chars": 42376, "metadata": { "page_count": 19, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q2\\extracted\\08119244\\08119244.extraction.json" } } ], "announcement_id": "1382806", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:42:15Z", "company": "Moberg Pharma AB", "title": "Moberg Pharmas delårsrapport januari - mars 2025", "category": "Interimsrapport", "date": "2025-05-13", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q1", "period": "2025-q1", "report_key": "2025:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=bd6c84ce0c3c9ee34fdd221209aed6946&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q1\\release.txt", "attachments": [ { "label": "05120994.pdf", "url": "https://attachment.news.eu.nasdaq.com/a53a15141ad43e9c9a9b3d1313756c139", "final_url": "https://attachment.news.eu.nasdaq.com/a53a15141ad43e9c9a9b3d1313756c139", "filename": "05120994.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q1\\05120994.pdf", "content_type": "application/pdf", "size": 628208, "sha256": "5f81368e9e8cb83ef48f8c90fb48c0b3bb319547a31c40892f0a3554a031f960", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q1\\05120994.pdf", "filename": "05120994.pdf", "extension": ".pdf", "size": 628208, "sha256": "5f81368e9e8cb83ef48f8c90fb48c0b3bb319547a31c40892f0a3554a031f960", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q1\\extracted\\05120994\\05120994.txt", "text_chars": 40066, "metadata": { "page_count": 19, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2025-q1\\extracted\\05120994\\05120994.extraction.json" } } ], "announcement_id": "1362752", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:42:28Z", "company": "Moberg Pharma AB", "title": "Moberg Pharmas årsredovisning för räkenskapsåret 2024 offentliggjord", "category": "Bokslut och Verksamhetsberättelse", "date": "2025-04-11", "language": "sv", "report_type": "annual-report", "fiscal_year": 2024, "quarter": "annual", "period": "2024-annual", "report_key": "2024:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b0436a81616efdca7b2ca3db153e05822&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-annual\\release.txt", "attachments": [ { "label": "04105917.pdf", "url": "https://attachment.news.eu.nasdaq.com/a49c5138d6bfe58b2666822812b59f4cc", "final_url": "https://attachment.news.eu.nasdaq.com/a49c5138d6bfe58b2666822812b59f4cc", "filename": "04105917.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-annual\\04105917.pdf", "content_type": "application/pdf", "size": 3288930, "sha256": "952c67c09b3a817cc9600b274370a0720b40aed9751b45fc8f8343d41f6b3342", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-annual\\04105917.pdf", "filename": "04105917.pdf", "extension": ".pdf", "size": 3288930, "sha256": "952c67c09b3a817cc9600b274370a0720b40aed9751b45fc8f8343d41f6b3342", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-annual\\extracted\\04105917\\04105917.txt", "text_chars": 237739, "metadata": { "page_count": 66, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-annual\\extracted\\04105917\\04105917.extraction.json" } } ], "announcement_id": "1355429", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:42:31Z", "company": "Moberg Pharma AB", "title": "Moberg Pharmas bokslutskommuniké 2024", "category": "Bokslutskommuniké", "date": "2025-02-11", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2024, "quarter": "q4", "period": "2024-q4", "report_key": "2024:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=baf90e9b2c925e7baab310cdfa38ccc32&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q4\\release.txt", "attachments": [ { "label": "02104805.pdf", "url": "https://attachment.news.eu.nasdaq.com/a49d7fcb0776498422b629a0d11658605", "final_url": "https://attachment.news.eu.nasdaq.com/a49d7fcb0776498422b629a0d11658605", "filename": "02104805.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q4\\02104805.pdf", "content_type": "application/pdf", "size": 657312, "sha256": "23d6c80cd1b24799649963b2004f5e86f8e0fc2580591994c7a4dffaa2b55c4e", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q4\\02104805.pdf", "filename": "02104805.pdf", "extension": ".pdf", "size": 657312, "sha256": "23d6c80cd1b24799649963b2004f5e86f8e0fc2580591994c7a4dffaa2b55c4e", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q4\\extracted\\02104805\\02104805.txt", "text_chars": 45172, "metadata": { "page_count": 20, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q4\\extracted\\02104805\\02104805.extraction.json" } } ], "announcement_id": "1342086", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:42:38Z", "company": "Moberg Pharma AB", "title": "Moberg Pharmas delårsrapport januari - september 2024", "category": "Interimsrapport", "date": "2024-11-12", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q3", "period": "2024-q3", "report_key": "2024:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=be716cc5324ebea79369e3fdfdcaa8de5&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q3\\release.txt", "attachments": [ { "label": "11115568.pdf", "url": "https://attachment.news.eu.nasdaq.com/a80f1a2120999595c11908852743cde4c", "final_url": "https://attachment.news.eu.nasdaq.com/a80f1a2120999595c11908852743cde4c", "filename": "11115568.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q3\\11115568.pdf", "content_type": "application/pdf", "size": 823643, "sha256": "605be590ea4094ba24a78272e651a3962e214d36b253761bc65ef6417ce9aaa9", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q3\\11115568.pdf", "filename": "11115568.pdf", "extension": ".pdf", "size": 823643, "sha256": "605be590ea4094ba24a78272e651a3962e214d36b253761bc65ef6417ce9aaa9", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q3\\extracted\\11115568\\11115568.txt", "text_chars": 46994, "metadata": { "page_count": 21, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q3\\extracted\\11115568\\11115568.extraction.json" } } ], "announcement_id": "1327213", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:42:42Z", "company": "Moberg Pharma AB", "title": "Moberg Pharmas delårsrapport januari - juni 2024", "category": "Interimsrapport", "date": "2024-08-13", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q2", "period": "2024-q2", "report_key": "2024:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=bc9580d8f46241b87364a8fc36a4fd081&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q2\\release.txt", "attachments": [ { "label": "08124063.pdf", "url": "https://attachment.news.eu.nasdaq.com/ad8c9de2d124edc7dc67a43c48400493d", "final_url": "https://attachment.news.eu.nasdaq.com/ad8c9de2d124edc7dc67a43c48400493d", "filename": "08124063.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q2\\08124063.pdf", "content_type": "application/pdf", "size": 656143, "sha256": "4434f8270a18cbbdc489caf4ade80d572d66aceaf88d6372284070856e0f8647", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q2\\08124063.pdf", "filename": "08124063.pdf", "extension": ".pdf", "size": 656143, "sha256": "4434f8270a18cbbdc489caf4ade80d572d66aceaf88d6372284070856e0f8647", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q2\\extracted\\08124063\\08124063.txt", "text_chars": 42791, "metadata": { "page_count": 19, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q2\\extracted\\08124063\\08124063.extraction.json" } } ], "announcement_id": "1310433", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:42:48Z", "company": "Moberg Pharma AB", "title": "Moberg Pharmas delårsrapport januari - mars 2024", "category": "Interimsrapport", "date": "2024-05-07", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q1", "period": "2024-q1", "report_key": "2024:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=ba510d2000cd66d39f964a1ac53f4cf53&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q1\\release.txt", "attachments": [ { "label": "05064576.pdf", "url": "https://attachment.news.eu.nasdaq.com/ac4858f04198212185bf639dd1ab14e12", "final_url": "https://attachment.news.eu.nasdaq.com/ac4858f04198212185bf639dd1ab14e12", "filename": "05064576.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q1\\05064576.pdf", "content_type": "application/pdf", "size": 827309, "sha256": "191531dfa0611531ab7b62a7617f4498806249ce5b012d7f92d420b336202034", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q1\\05064576.pdf", "filename": "05064576.pdf", "extension": ".pdf", "size": 827309, "sha256": "191531dfa0611531ab7b62a7617f4498806249ce5b012d7f92d420b336202034", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q1\\extracted\\05064576\\05064576.txt", "text_chars": 39027, "metadata": { "page_count": 19, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2024-q1\\extracted\\05064576\\05064576.extraction.json" } } ], "announcement_id": "1293861", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:43:08Z", "company": "Moberg Pharma AB", "title": "Moberg Pharmas årsredovisning för räkenskapsåret 2023 offentliggjord", "category": "Bokslut och Verksamhetsberättelse", "date": "2024-04-12", "language": "sv", "report_type": "annual-report", "fiscal_year": 2023, "quarter": "annual", "period": "2023-annual", "report_key": "2023:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b96d30a7261becb4fa9bce4714dffd517&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-annual\\release.txt", "attachments": [ { "label": "04110439.pdf", "url": "https://attachment.news.eu.nasdaq.com/aa992845d56c11ed656a9e84a2417670a", "final_url": "https://attachment.news.eu.nasdaq.com/aa992845d56c11ed656a9e84a2417670a", "filename": "04110439.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-annual\\04110439.pdf", "content_type": "application/pdf", "size": 6150032, "sha256": "35d5862def1400adb3c8886f003cc0bdadb010b6eb94798b112c55125e05e461", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-annual\\04110439.pdf", "filename": "04110439.pdf", "extension": ".pdf", "size": 6150032, "sha256": "35d5862def1400adb3c8886f003cc0bdadb010b6eb94798b112c55125e05e461", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-annual\\extracted\\04110439\\04110439.txt", "text_chars": 236217, "metadata": { "page_count": 69, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-annual\\extracted\\04110439\\04110439.extraction.json" } } ], "announcement_id": "1287477", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:43:10Z", "company": "Moberg Pharma AB", "title": "Bokslutskommuniké 2023", "category": "Bokslutskommuniké", "date": "2024-02-13", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2023, "quarter": "q4", "period": "2023-q4", "report_key": "2023:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=bffbd5de14e3656e097b40015e2307764&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q4\\release.txt", "attachments": [ { "label": "02126814.pdf", "url": "https://attachment.news.eu.nasdaq.com/a18b0f28e1473af0169520a46183acb6d", "final_url": "https://attachment.news.eu.nasdaq.com/a18b0f28e1473af0169520a46183acb6d", "filename": "02126814.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q4\\02126814.pdf", "content_type": "application/pdf", "size": 681901, "sha256": "2ea9b564a8142e5b48190c78bd69c156624a7f2a277a8562b2733aa12446a2e4", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q4\\02126814.pdf", "filename": "02126814.pdf", "extension": ".pdf", "size": 681901, "sha256": "2ea9b564a8142e5b48190c78bd69c156624a7f2a277a8562b2733aa12446a2e4", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q4\\extracted\\02126814\\02126814.txt", "text_chars": 41832, "metadata": { "page_count": 20, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q4\\extracted\\02126814\\02126814.extraction.json" } } ], "announcement_id": "1274362", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:43:16Z", "company": "Moberg Pharma AB", "title": "Moberg Pharmas delårsrapport januari - september 2023", "category": "Interimsrapport", "date": "2023-11-07", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q3", "period": "2023-q3", "report_key": "2023:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b20e28bb9d5e601dcc82671e76432a626&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q3\\release.txt", "attachments": [ { "label": "11069198.pdf", "url": "https://attachment.news.eu.nasdaq.com/a13541e6792fa90aacea1c7c49dcc5d72", "final_url": "https://attachment.news.eu.nasdaq.com/a13541e6792fa90aacea1c7c49dcc5d72", "filename": "11069198.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q3\\11069198.pdf", "content_type": "application/pdf", "size": 669723, "sha256": "f5e96900782a0e062251b8a70fa43050da7f0e4490216e0158a22d679d1f8077", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q3\\11069198.pdf", "filename": "11069198.pdf", "extension": ".pdf", "size": 669723, "sha256": "f5e96900782a0e062251b8a70fa43050da7f0e4490216e0158a22d679d1f8077", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q3\\extracted\\11069198\\11069198.txt", "text_chars": 44269, "metadata": { "page_count": 21, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q3\\extracted\\11069198\\11069198.extraction.json" } } ], "announcement_id": "1257565", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:43:21Z", "company": "Moberg Pharma AB", "title": "Moberg Pharmas delårsrapport januari - juni 2023", "category": "Interimsrapport", "date": "2023-08-03", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q2", "period": "2023-q2", "report_key": "2023:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b1082d35e4d8460c273e1caea48cac238&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q2\\release.txt", "attachments": [ { "label": "08021298.pdf", "url": "https://attachment.news.eu.nasdaq.com/a3ace2efddca7c5f5f301e7a02b74dff4", "final_url": "https://attachment.news.eu.nasdaq.com/a3ace2efddca7c5f5f301e7a02b74dff4", "filename": "08021298.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q2\\08021298.pdf", "content_type": "application/pdf", "size": 809343, "sha256": "4b01c41ebadd918f34d97d01cf82049932396e2eadaa2fc1a503995ff3c2f3d0", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q2\\08021298.pdf", "filename": "08021298.pdf", "extension": ".pdf", "size": 809343, "sha256": "4b01c41ebadd918f34d97d01cf82049932396e2eadaa2fc1a503995ff3c2f3d0", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q2\\extracted\\08021298\\08021298.txt", "text_chars": 40267, "metadata": { "page_count": 19, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q2\\extracted\\08021298\\08021298.extraction.json" } } ], "announcement_id": "1241000", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T05:43:26Z", "company": "Moberg Pharma AB", "title": "Moberg Pharmas delårsrapport januari - mars 2023", "category": "Interimsrapport", "date": "2023-05-09", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q1", "period": "2023-q1", "report_key": "2023:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b5d0b7483d8b050ed5339da2cc91f932c&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q1\\release.txt", "attachments": [ { "label": "05084027.pdf", "url": "https://attachment.news.eu.nasdaq.com/a48aae1f357bb375199230e6b5ed706ad", "final_url": "https://attachment.news.eu.nasdaq.com/a48aae1f357bb375199230e6b5ed706ad", "filename": "05084027.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q1\\05084027.pdf", "content_type": "application/pdf", "size": 767635, "sha256": "46e2f3a7c3f65a498963bae953eda6477c4a41b7a28e0175c548cbe4dc5acc7a", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q1\\05084027.pdf", "filename": "05084027.pdf", "extension": ".pdf", "size": 767635, "sha256": "46e2f3a7c3f65a498963bae953eda6477c4a41b7a28e0175c548cbe4dc5acc7a", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q1\\extracted\\05084027\\05084027.txt", "text_chars": 32537, "metadata": { "page_count": 18, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\moberg-pharma\\nasdaq-reports\\reports\\2023-q1\\extracted\\05084027\\05084027.extraction.json" } } ], "announcement_id": "1226414", "status": "retrieved" } ], "attempts": [ { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Moberg+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Moberg Pharma", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "09e1fb4f10eed46a7f6a24762cc3cd096bb5d4b9aa4e3f7ced22cb9e40d9ec8d" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Moberg+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "Moberg Pharma", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "d44a3924a21d738df0e59622454556b22625c38d52af83d27a23254cfb178bfd" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Moberg+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 200, "pagination": "row-offset", "query_text": "Moberg Pharma", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "d4acc78210f99a23205d48c2b4558b90ecfdc8adafe1e5912dc5e5a0761ce0ef" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Moberg+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 300, "pagination": "row-offset", "query_text": "Moberg Pharma", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 50, "new_rows": 50, "total_count": null, "from_cache": false, "body_sha256": "fb98bc0c781e5ccb2f3500dd6497cac3ca8b6001656d513f5b4e0e1696abc711" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Moberg+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=350&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 350, "pagination": "row-offset", "query_text": "Moberg Pharma", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "008ad52fa909950210ad8c1b03b071502d75054863250872c44a7455e7af6dab" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Moberg+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Moberg Pharma", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 21, "new_rows": 21, "total_count": null, "from_cache": false, "body_sha256": "5d334a5d7b98c88f38b0065ca257ec688a8d5e72c7e314b38e49d35e416bf26c" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Moberg+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=21&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 21, "pagination": "row-offset", "query_text": "Moberg Pharma", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "bf1e6787fe5b426774a68a6994c4375c988c476072ad52acc094f303c257f21a" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Moberg+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Moberg Pharma", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "c06136066b4972a318e035c59ae672cc420b42887e1290a3c6f6842e950bf3b0" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Moberg+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "Moberg Pharma", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "6f9be0a57fdafad2b10874a971b9f3a6ac612fc9462f5691e22c22d141ee8b32" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Moberg+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 200, "pagination": "row-offset", "query_text": "Moberg Pharma", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "796fa24cdc73bff8be2bde04d8655dc200919bdf69acca9c60003914ab959963" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Moberg+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 300, "pagination": "row-offset", "query_text": "Moberg Pharma", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 50, "new_rows": 50, "total_count": null, "from_cache": false, "body_sha256": "925b0fa74b31a3703446587001bf1f9376bdca8237d5b7c4c80e54cb96148e44" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Moberg+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=350&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 350, "pagination": "row-offset", "query_text": "Moberg Pharma", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "008ad52fa909950210ad8c1b03b071502d75054863250872c44a7455e7af6dab" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Moberg+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Moberg Pharma", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 8, "new_rows": 8, "total_count": null, "from_cache": false, "body_sha256": "655f59627cf5631e09e8b764e7a83b1c70aa40cd502e7189f44db51a01e18b10" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Moberg+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=8&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 8, "pagination": "row-offset", "query_text": "Moberg Pharma", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "55f851bae00890b2e785c04c1fe6322bd70256e1e6d4d26272bd41a04cf045af" } ], "identity": { "slug": "", "instrument_id": "TX895320", "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/mob?id=TX895320" }, "transport": "ordinary-http", "browser_used": false, "query_text": "Moberg Pharma", "retrieved_at": "2026-08-07T05:43:26Z" }